The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/10931080

Download in:

View as

Triples

General Info

PMID
10931080